1. Medtech Insight
  2. >>Business
  3. >>Financing

MedLumics Closes $21.7M Financing To Support Optically Guided Ablation Catheter

 
• By Reed Miller

The Madrid, Spain-based company is developing the AblaView ablation catheter for treating atrial fibrillation.

Medical monitor with green lines of an abnormal ECG showing atrial fibrillation, a red line for the arterial blood pressure and a blue line for the oxygen saturation against a black background.

MedLumics S.L. has completed an €18m ($21.7m) financing to support the ongoing development of its AblaView cardiac ablation catheter, the Madrid-based company announced on 10 February.

Asabys Partners and Kurma Partners led the financing with contributions from new investors VI Partners Swiss Innovation and CDTI Innvierte Economía, as well as existing investors Andera Partners, Caixa Capital...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business